Cargando…
Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease
BACKGROUND: Serum troponin assays, widely used to detect acute cardiac ischemia, might be useful biomarkers to detect chronic cardiovascular disease (CVD). Cardiac-specific troponin-I (cTnI) and troponin-T (cTnT) generally detect myocardial necrosis equally well. In dialysis patients however, serum...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523186/ https://www.ncbi.nlm.nih.gov/pubmed/26237313 http://dx.doi.org/10.1371/journal.pone.0134245 |
_version_ | 1782384045766737920 |
---|---|
author | Buiten, Maurits S. de Bie, Mihály K. Rotmans, Joris I. Dekker, Friedo W. van Buren, Marjolijn Rabelink, Ton J. Cobbaert, Christa M. Schalij, Martin J. van der Laarse, Arnoud Jukema, J. Wouter |
author_facet | Buiten, Maurits S. de Bie, Mihály K. Rotmans, Joris I. Dekker, Friedo W. van Buren, Marjolijn Rabelink, Ton J. Cobbaert, Christa M. Schalij, Martin J. van der Laarse, Arnoud Jukema, J. Wouter |
author_sort | Buiten, Maurits S. |
collection | PubMed |
description | BACKGROUND: Serum troponin assays, widely used to detect acute cardiac ischemia, might be useful biomarkers to detect chronic cardiovascular disease (CVD). Cardiac-specific troponin-I (cTnI) and troponin-T (cTnT) generally detect myocardial necrosis equally well. In dialysis patients however, serum cTnT levels are often elevated, unlike cTnI levels. The present study aims to elucidate the associations of cTnI and cTnT with CVD in clinically stable dialysis patients. METHODS: Troponin levels were measured using 5(th) generation hs-cTnT assays (Roche) and STAT hs-cTnI assays (Abbott) in a cohort of dialysis patients. Serum troponin levels were divided into tertiles with the lowest tertile as a reference value. Serum troponins were associated with indicators of CVD such as left ventricular mass index (LVMI), left ventricular ejection fraction (LVEF) and the presence of coronary artery disease (CAD). Associations were explored using regression analysis. RESULTS: We included 154 consecutive patients, 68±7 years old, 77% male, 70% hemodialysis. Median serum cTnT was 51ng/L (exceeding the 99(th) percentile of the healthy population in 98%) and median serum cTnI was 13ng/L (elevated in 20%). A high cTnI (T3) was significantly associated with a higher LVMI (Beta 31.60; p=0.001) and LVEF (Beta -4.78; p=0.005) after adjusting for confounders whereas a high serum cTnT was not. CAD was significantly associated with a high cTnT (OR 4.70 p=0.02) but not with a high cTnI. Unlike cTnI, cTnT was associated with residual renal function (Beta:-0.09; p=0.006). CONCLUSION: In the present cohort, serum cTnI levels showed a stronger association with LVMI and LVEF than cTnT. However, cTnT was significantly associated with CAD and residual renal function, unlike cTnI. Therefore, cTnI seems to be superior to cTnT as a marker of left ventricular dysfunction in asymptomatic dialysis patients, while cTnT might be better suited to detect CAD in these patients. |
format | Online Article Text |
id | pubmed-4523186 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-45231862015-08-06 Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease Buiten, Maurits S. de Bie, Mihály K. Rotmans, Joris I. Dekker, Friedo W. van Buren, Marjolijn Rabelink, Ton J. Cobbaert, Christa M. Schalij, Martin J. van der Laarse, Arnoud Jukema, J. Wouter PLoS One Research Article BACKGROUND: Serum troponin assays, widely used to detect acute cardiac ischemia, might be useful biomarkers to detect chronic cardiovascular disease (CVD). Cardiac-specific troponin-I (cTnI) and troponin-T (cTnT) generally detect myocardial necrosis equally well. In dialysis patients however, serum cTnT levels are often elevated, unlike cTnI levels. The present study aims to elucidate the associations of cTnI and cTnT with CVD in clinically stable dialysis patients. METHODS: Troponin levels were measured using 5(th) generation hs-cTnT assays (Roche) and STAT hs-cTnI assays (Abbott) in a cohort of dialysis patients. Serum troponin levels were divided into tertiles with the lowest tertile as a reference value. Serum troponins were associated with indicators of CVD such as left ventricular mass index (LVMI), left ventricular ejection fraction (LVEF) and the presence of coronary artery disease (CAD). Associations were explored using regression analysis. RESULTS: We included 154 consecutive patients, 68±7 years old, 77% male, 70% hemodialysis. Median serum cTnT was 51ng/L (exceeding the 99(th) percentile of the healthy population in 98%) and median serum cTnI was 13ng/L (elevated in 20%). A high cTnI (T3) was significantly associated with a higher LVMI (Beta 31.60; p=0.001) and LVEF (Beta -4.78; p=0.005) after adjusting for confounders whereas a high serum cTnT was not. CAD was significantly associated with a high cTnT (OR 4.70 p=0.02) but not with a high cTnI. Unlike cTnI, cTnT was associated with residual renal function (Beta:-0.09; p=0.006). CONCLUSION: In the present cohort, serum cTnI levels showed a stronger association with LVMI and LVEF than cTnT. However, cTnT was significantly associated with CAD and residual renal function, unlike cTnI. Therefore, cTnI seems to be superior to cTnT as a marker of left ventricular dysfunction in asymptomatic dialysis patients, while cTnT might be better suited to detect CAD in these patients. Public Library of Science 2015-08-03 /pmc/articles/PMC4523186/ /pubmed/26237313 http://dx.doi.org/10.1371/journal.pone.0134245 Text en © 2015 Buiten et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Buiten, Maurits S. de Bie, Mihály K. Rotmans, Joris I. Dekker, Friedo W. van Buren, Marjolijn Rabelink, Ton J. Cobbaert, Christa M. Schalij, Martin J. van der Laarse, Arnoud Jukema, J. Wouter Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease |
title | Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease |
title_full | Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease |
title_fullStr | Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease |
title_full_unstemmed | Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease |
title_short | Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease |
title_sort | serum cardiac troponin-i is superior to troponin-t as a marker for left ventricular dysfunction in clinically stable patients with end-stage renal disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523186/ https://www.ncbi.nlm.nih.gov/pubmed/26237313 http://dx.doi.org/10.1371/journal.pone.0134245 |
work_keys_str_mv | AT buitenmauritss serumcardiactroponiniissuperiortotroponintasamarkerforleftventriculardysfunctioninclinicallystablepatientswithendstagerenaldisease AT debiemihalyk serumcardiactroponiniissuperiortotroponintasamarkerforleftventriculardysfunctioninclinicallystablepatientswithendstagerenaldisease AT rotmansjorisi serumcardiactroponiniissuperiortotroponintasamarkerforleftventriculardysfunctioninclinicallystablepatientswithendstagerenaldisease AT dekkerfriedow serumcardiactroponiniissuperiortotroponintasamarkerforleftventriculardysfunctioninclinicallystablepatientswithendstagerenaldisease AT vanburenmarjolijn serumcardiactroponiniissuperiortotroponintasamarkerforleftventriculardysfunctioninclinicallystablepatientswithendstagerenaldisease AT rabelinktonj serumcardiactroponiniissuperiortotroponintasamarkerforleftventriculardysfunctioninclinicallystablepatientswithendstagerenaldisease AT cobbaertchristam serumcardiactroponiniissuperiortotroponintasamarkerforleftventriculardysfunctioninclinicallystablepatientswithendstagerenaldisease AT schalijmartinj serumcardiactroponiniissuperiortotroponintasamarkerforleftventriculardysfunctioninclinicallystablepatientswithendstagerenaldisease AT vanderlaarsearnoud serumcardiactroponiniissuperiortotroponintasamarkerforleftventriculardysfunctioninclinicallystablepatientswithendstagerenaldisease AT jukemajwouter serumcardiactroponiniissuperiortotroponintasamarkerforleftventriculardysfunctioninclinicallystablepatientswithendstagerenaldisease |